Patients receiving neoadjuvant short-course radiotherapy (SCRT) or chemoradiotherapy (CRT) for primary non-metastasized rectal cancer may achieve a clinical complete response and can be surveilled following the watch and wait strategy.
The aim of this study is to investigate the utilization of this strategy using nationwide data from the Netherlands Cancer Registry.
